Open menu
Nanowerk

Nanotechnology Business News

The latest product and company news

RSS Subscribe to our Nanotechnology Business News feed

mPhase Released Video of Smart NanoBattery Technology

mPhase Technologies, Inc. today released a short, non-narrated, rough footage, technical video highlighting its smart surface technology, that illustrates the design elements that make up the final assembly of its first multi cell Smart NanoBattery.

Posted: Nov 1st, 2010

Read more

Roche Partners with DNA Electronics to Develop Semiconductor-Based Sequencing System

454 Life Sciences, a Roche Company, announced today that it has entered an exclusive partnership with DNA Electronics for the development of a low-cost, high-throughput DNA sequencing system. As part of the agreement, Roche has signed a non-exclusive license for relevant IP from DNA Electronics' proprietary semiconductor technology portfolio, which enables sensitive detection of nucleotide incorporation during sequencing.

Posted: Nov 1st, 2010

Read more

Lumerical Solutions' FDTD Solutions 7.0 Delivers Optimization and Conformal Meshing to Photonic Design

Lumerical Solutions Inc., a global provider of nanophotonic design software, today unveiled innovative improvements to its flagship product FDTD Solutions 7.0. Improvements to FDTD Solutions 7.0 include an integrated parameter sweep and optimization environment, industry's first conformal mesh for nanophotonic design, an extended set of simulation primitives to facilitate the design of complex devices and support for Mac OS X.

Posted: Oct 29th, 2010

Read more

Access Pharmaceuticals Signs Agreement With Leading Biopharmaceutical Company to Develop CobOral Formulation of Widely-Marketed Injectable

Access Pharmaceuticals, Inc., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into a pre-licensing feasibility agreement with a leading biopharmaceutical company to develop an oral formulation of an undisclosed prostate cancer compound utilizing its proprietary vitamin B-12-based CobOral Drug Delivery Technology.

Posted: Oct 29th, 2010

Read more